Anja-Katrin Bosserhoff

Author PubWeight™ 64.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J 2002 1.72
2 Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 2004 1.61
3 Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 2009 1.60
4 Multiparameter immunofluorescence on paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol 2006 1.59
5 Integrin signaling in malignant melanoma. Cancer Metastasis Rev 2005 1.58
6 Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 2005 1.49
7 Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis. J Am Coll Cardiol 2008 1.43
8 Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. Am J Pathol 2003 1.36
9 Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncol 2008 1.27
10 MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cell Mol Life Sci 2010 1.16
11 MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. Int J Cancer 2011 1.12
12 Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo. Gastroenterology 2009 1.11
13 Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factors. PLoS One 2009 1.10
14 Epigenetic events in malignant melanoma. Pigment Cell Res 2007 1.10
15 Cold atmospheric plasma (CAP) changes gene expression of key molecules of the wound healing machinery and improves wound healing in vitro and in vivo. PLoS One 2013 1.09
16 Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. Carcinogenesis 2005 1.09
17 Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. J Pathol 2009 1.08
18 Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. Mol Cell Biol 2002 1.06
19 A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol 2006 1.06
20 Cold atmospheric plasma, a new strategy to induce senescence in melanoma cells. Exp Dermatol 2013 1.04
21 Fussel-15, a novel Ski/Sno homolog protein, antagonizes BMP signaling. Mol Cell Neurosci 2007 1.03
22 p54nrb is a new regulator of progression of malignant melanoma. Carcinogenesis 2011 1.01
23 Constitutive HIF-1 activity in malignant melanoma. Eur J Cancer 2010 0.99
24 Identification and embryonic expression of a new AP-2 transcription factor, AP-2 epsilon. Dev Dyn 2004 0.98
25 Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur Heart J 2004 0.97
26 Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation. Proc Natl Acad Sci U S A 2012 0.96
27 BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells. Exp Mol Pathol 2011 0.95
28 Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels. Cell Res 2010 0.94
29 Modulation of cartilage differentiation by melanoma inhibiting activity/cartilage-derived retinoic acid-sensitive protein (MIA/CD-RAP). Exp Mol Med 2010 0.94
30 Cloning and functional characterization of a new Ski homolog, Fussel-18, specifically expressed in neuronal tissues. Lab Invest 2005 0.93
31 Characterization of Sno expression in malignant melanoma. Int J Oncol 2005 0.93
32 Regulation of integrin activity by MIA. J Biol Chem 2006 0.92
33 Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro. PLoS One 2013 0.91
34 Downregulation of N-cadherin in the neointima stimulates migration of smooth muscle cells by RhoA deactivation. Cardiovasc Res 2004 0.90
35 Deregulation of protein methylation in melanoma. Eur J Cancer 2012 0.90
36 In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers. Liver Int 2005 0.89
37 Interactions of TANGO and leukocyte integrin CD11c/CD18 regulate the migration of human monocytes. J Leukoc Biol 2007 0.89
38 A heart-hand syndrome gene: Tfap2b plays a critical role in the development and remodeling of mouse ductus arteriosus and limb patterning. PLoS One 2011 0.88
39 Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin. Lab Invest 2005 0.88
40 Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth. Am J Pathol 2010 0.88
41 Processing of MIA protein during melanoma cell migration. Int J Cancer 2009 0.87
42 Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration. Cancer Sci 2009 0.86
43 Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells. J Vasc Res 2002 0.85
44 Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. Dev Biol 2008 0.84
45 Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases. Exp Dermatol 2012 0.84
46 Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas. J Neurooncol 2005 0.84
47 FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29. Oncol Rep 2010 0.83
48 Fussel-15, a new player in wound healing, is deregulated in keloid and localized scleroderma. Am J Pathol 2011 0.83
49 The evolving concept of 'melano-miRs'-microRNAs in melanomagenesis. Pigment Cell Melanoma Res 2010 0.83
50 Development of a model system to analyze chondrogenic differentiation of mesenchymal stem cells. Int J Clin Exp Pathol 2013 0.83
51 Expression and function of the atypical cadherin FAT1 in chronic liver disease. Biochem Biophys Res Commun 2012 0.82
52 Bone morphogenetic proteins induce expression of metalloproteinases in melanoma cells and fibroblasts. Eur J Cancer 2008 0.82
53 Reduced expression of beta-catenin inhibitor Chibby in colon carcinoma cell lines. World J Gastroenterol 2006 0.82
54 Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma. Lab Invest 2011 0.81
55 Detailed analysis of MIA protein by mutagenesis. Biol Chem 2006 0.81
56 Melanoma inhibitory activity promotes melanoma development through activation of YBX1. Pigment Cell Melanoma Res 2013 0.79
57 Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma. Oncol Rep 2004 0.79
58 Decrease of vascular smooth muscle cell locomotion by abciximab, but not tirofiban: a possible role of different affinity to alpha v beta 3 integrins. Coron Artery Dis 2002 0.79
59 Backbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains. Protein Sci 2003 0.78
60 Expression patterns of integrins on quiescent and invasive smooth muscle cells and impact on cell locomotion. J Mol Cell Cardiol 2002 0.78
61 Expression and function of methylthioadenosine phosphorylase in chronic liver disease. PLoS One 2013 0.78
62 Enhanced migration of tissue inhibitor of metalloproteinase overexpressing hepatoma cells is attributed to gelatinases: relevance to intracellular signaling pathways. World J Gastroenterol 2005 0.77
63 MIA--a new target protein for malignant melanoma therapy. Histol Histopathol 2012 0.77
64 Role of deleted in colon carcinoma in osteoarthritis and in chondrocyte migration. Rheumatology (Oxford) 2009 0.77
65 Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma. Melanoma Res 2006 0.76
66 fussel (fuss)--A negative regulator of BMP signaling in Drosophila melanogaster. PLoS One 2012 0.75
67 Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected]. J Invest Dermatol 2002 0.75
68 DNA staining in agarose gels with Zn²+-cyclen-pyrene. Nucleosides Nucleotides Nucleic Acids 2010 0.75